AET - Aetna Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
199.73
+0.87 (+0.44%)
As of 1:06PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close198.86
Open199.00
Bid199.70 x 800
Ask199.70 x 1100
Day's Range199.00 - 199.95
52 Week Range149.69 - 199.95
Volume464,984
Avg. Volume1,862,220
Market Cap65.332B
Beta0.77
PE Ratio (TTM)18.83
EPS (TTM)10.61
Earnings DateOct 29, 2018 - Nov 2, 2018
Forward Dividend & Yield2.00 (1.01%)
Ex-Dividend Date2018-07-24
1y Target Est203.00
Trade prices are not sourced from all markets
  • TheStreet.com5 days ago

    Aetna Reached Our Target Price and Is Still Bullish

    Now that AET has finally reached our target area a fresh look is certainly warranted and perhaps overdue. In this daily bar chart of AET, below, we can see that prices have been in an uptrend the past 12 months. The daily On-Balance-Volume (OBV) line has been moving up with the price action from early April.

  • Aetna Launches Scheme for Better Patient Care Amenities
    Zacks5 days ago

    Aetna Launches Scheme for Better Patient Care Amenities

    Aetna (AET) proposes a new regional plan to serve employers better.

  • Business Wire7 days ago

    Aetna Collaborates with Four Local Health Systems, Introduces Regional Aetna Whole Health℠ - Southern California Plan

    Aetna has introduced the regional Aetna Whole Health - Southern California plan to employers with employees in San Diego County, Orange County, Los Angeles County and select portions of the Inland Empire.

  • CNBC10 days ago

    Here's how the proposed CVS-Aetna merger could increase costs, restrict access

    The U.S. Department of Justice may not have plans to challenge the $69 billion mega-merger of CVS and Aetna. Dr. Theresa Rohr-Kirchgraber said the deal could severely limit patient choice when it comes to seeing a doctor or filling a prescription, and will almost certainly increase health-care costs by providing even less transparency into the already murky world of prescription drug prices. While the U.S. Department of Justice may not have plans to challenge the $69 billion mega-merger of CVS CVS and Aetna AET , patients and physicians should do so at every turn.

  • CVS Health Corporation's Prescription Growth Outweighs Long-Term Care Woes
    Motley Fool12 days ago

    CVS Health Corporation's Prescription Growth Outweighs Long-Term Care Woes

    The pharmacy services giant reported strong prescription volume growth in the second quarter but a big writedown for its struggling LTC business.

  • Reuters12 days ago

    American Medical Association opposes merger of CVS and Aetna

    The American Medical Association, which represents U.S. physicians, urged the U.S. Justice Department on Wednesday to stop CVS Health Corp's plan to buy insurance provider Aetna Inc, saying the deal could result in higher prices for prescription medicines. The AMA said that the $69 billion deal, announced in December, would lead to a "substantial reduction" of competition in pharmacy benefit (PBM) services market and the Medicare Part D prescription drug plan for seniors. The AMA said the deal would increase concentration in 10 of the 34 Medicare Part D regional markets to the point where it is presumed likely to increase market power.

  • Market Exclusive12 days ago

    Market Morning: Musk Nukes Tesla Shorts, Negatively Priced Power, Samsung All In on AI

    Musk Pulls Nuclear Option on Tesla Shorts In quite a clever move that amounts to a surprise squeeze on Tesla (NASDAQ:TSLA) shorts, the notorious and constantly-in-the-news for one thing or another Tesla CEO Elon Musk proposed taking Tesla private yesterday, which rocketed shares higher 11%. The deal he proposed and says that he has somehow […] The post Market Morning: Musk Nukes Tesla Shorts, Negatively Priced Power, Samsung All In on AI appeared first on Market Exclusive.

  • Bloomberg13 days ago

    CVS-Aetna Deal Dodges Antitrust Hurdle That AT&T Faced

    CVS Health Corp. has dodged one hurdle in its bid to buy insurer Aetna Inc., as antitrust enforcers don’t see competitive problems that can stem from uniting companies that operate at different levels of a supply chain, according to two people familiar with the matter. The investigation by the Justice Department’s antitrust division hasn’t turned up vertical- competition concerns from the merger, according to the people, who declined to be identified because the review is confidential. CVS’s $68 billion deal to buy Aetna was announced on the heels of the Justice Department’s unsuccessful lawsuit to block AT&T Inc.’s takeover of Time Warner Inc., a vertical deal that combined a pay-TV distributor with a programmer.

  • What Has Subdued CVS Health’s Stock Price in 2018?
    Market Realist14 days ago

    What Has Subdued CVS Health’s Stock Price in 2018?

    Competitor Walgreens Boots Alliance (WBA) has also fallen 7.8% so far this year. Amazon’s (AMZN) foray into the pharma space with the PillPack acquisition, and the ongoing uncertainty arising from the Trump administration’s recommendations on how PBMs would receive rebates, has impacted drugstore stocks adversely. Amazon’s acquisition announcement of PillPack on June 28 resulted in respective declines of 6.0% and 9.0% in the stock prices of CVS Health and Walgreens.

  • Investopedia14 days ago

    CVS Health Reports Earnings Below Key Chart Levels

    Drug store giant CVS Health Corporation ( CVS) set its all-time intraday high of $113.65 at the end of July 2015 and has been a laggard since then. The pharmacy stock suffered under pressure from Amazon.com, Inc.'s ( AMZN) plan to expand into the healthcare industry. CVS stock traded as low as $60.14 on March 27 as the company countered with its plan to take over health insurer Aetna Inc. ( AET).

  • Investopedia17 days ago

    Health Insurance Carriers Headed for New Highs

    The dismantling of the Affordable Care Act (ACA), also known as Obamacare, and a deregulatory wave across affected states is underpinning profits, while the domestic focus of the health insurance companies is offering safe haven against trade war headwinds. Humana Inc. ( HUM) beat second quarter profit expectations by 18 cents while guiding fiscal year 2018 above consensus. Humana has competed with Dow component UnitedHealth Group Incorporated ( UNH) for industry leadership in recent years, matching rally leg for rally leg.

  • Aetna (AET) Q2 Earnings Beat Estimates, Membership Declines
    Zacks18 days ago

    Aetna (AET) Q2 Earnings Beat Estimates, Membership Declines

    Aetna's (AET) Q2 earnings gained from a lower tax rate partly offset by increase in expenses.

  • Aetna easily exceeds 2Q expectations
    Associated Press18 days ago

    Aetna easily exceeds 2Q expectations

    Aetna easily topped second-quarter earnings expectations as another drop in benefit expenses and lower taxes helped the nation's third-largest health insurer. Analysts expected, on average, $3.07 per share, according to Zacks Investment Research. Aetna didn't offer a 2018 forecast or discuss results with analysts Thursday due to its pending acquisition by the drugstore chain and pharmacy benefit manager CVS Health Corp. The companies announced that roughly $69-billion deal late last year and expect it to close in the second half of 2018.

  • Aetna (AET) Q2 Earnings and Revenues Beat Estimates
    Zacks18 days ago

    Aetna (AET) Q2 Earnings and Revenues Beat Estimates

    Aetna (AET) delivered earnings and revenue surprises of 11.73% and 0.83%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

  • MarketWatch18 days ago

    Aetna reports Q2 profit, revenue beats

    MARKET PULSE Aetna Inc. (AET) reported second-quarter profit and revenue beats early Thursday. Shares were inactive in premarket trade. Earnings for the latest quarter rose to $1.21 billion, or $3.67 per share, from $1.

  • Business Wire18 days ago

    Aetna Reports Second-Quarter 2018 Results

    Aetna announced second-quarter 2018 net income of approximately $1.2 billion, or $3.67 per share. Adjusted earnings for second-quarter 2018 were approximately $1.1 billion, or $3.43 per share.

  • Benzinga19 days ago

    Aetna Q2 Earnings Preview

    On Thursday, Aetna (NYSE: AET ) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release. Earnings and Revenue Analysts predict Aetna ...

  • Will a Decline in Membership Mar Aetna's (AET) Q2 Earnings?
    Zacks20 days ago

    Will a Decline in Membership Mar Aetna's (AET) Q2 Earnings?

    Aetna (AET) Q2 earnings to suffer from lower membership and revenues partly offset by a lower tax rate.

  • 5 Domestic Stocks That Crush Trade War Fears
    InvestorPlace27 days ago

    5 Domestic Stocks That Crush Trade War Fears

    As global trade tensions play havoc with the financial markets, one strategy is to consider stocks with relatively large domestic sales exposure. This is the tactic recommended by Goldman Sachs. “Below the surface of the market, trade conflict would benefit the performance of the most domestic-facing U.S. stocks relative to the most foreign-facing firms,” the firm says. This is according to a recent warning from International Monetary Fund (IMF).

  • NYU plans free tuition for medical school students
    Yahoo Finance Video3 days ago

    NYU plans free tuition for medical school students

    NYU School of Medicine announces plans to offer full scholarships to all students, covering a yearly tuition of $55,018. Yahoo Finance's Seana Smith, Pras Subramanian, Andy Serwer and Dan Howley discuss.